AA & MDSIF Bone Marrow Failure Disease Symposium
Since bone marrow failure diseases are rare, clinicians may not be aware of the presenting signs and symptoms and thus delay earlier diagnosis and treatment.
Practitioners who see very few bone marrow failure disease patients may not be up-to-date on the clinical implications of cytogenetic and molecular abnormalities on diagnosis and treatment.
Clinicians may be relying only on bone marrow biopsies and not the latest technology to determine the pathogenesis and therapeutic options for bone marrow failure diseases.
Practitioners may not see many bone marrow failure disease patients and thus are not up-to-date on recent advances in treatment options;
Transplantation for bone marrow failure diseases may not be considered for patients over a certain age or without a related matched donor.
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and AA MDS International Foundation. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.5 hours of participation for continuing education for allied health professionals.
12:20 noon – 1:00 pm | Registration and Lunch |
1:00 pm – 1:10 pm | Welcome by Course Director Ehab Atallah, MD |
1:10 pm – 2:00 pm | Aplastic Anemia & PNH |
2:00 pm – 2:45 pm | Myelodysplastic Syndromes (MDS) |
2:45 pm – 3:00 pm | Break |
3:00 pm – 3:40 pm | Myeloproliferative Neoplasms (MPN) |
3:40 pm – 4:10 pm | Hematopoietic Stem Cell Transplantation |
4:10 pm – 4:40 pm | Diagnostic Challenges: The Pathologists Perspective |
4:40 pm – 5:00 pm | Panel Discussion |
Jointly provided by The Medical College of Wisconsin and the AA MDS International Foundation |
Target Audience
Physicians and Allied Health Care Professionals
Learning Objectives
- Provide accurate differential diagnosis of bone marrow failure diseases, including MDS, aplastic anemia, PNH and MPN;
- Critically appraise recent advances in research on the genetic characteristics of bone marrow failure diseases;
- Summarize recent progress in understanding the pathogenesis of myeloid malignancies and bone marrow failure diseases
- Describe safety and efficacy data for currently available therapies for bone marrow failure diseases;
- Identify current therapeutic standards, as well as new and emerging therapies used in HCT.
Crowne Plaza Milwaukee West
10499 Innovation Drive
Wauwatosa, WI 53226
Registration Information
Registration is required for this complementary course.
Jaroslaw Maciejewski, MD, PhD
Chairman of Translational Hematology and Oncology Research
Cleveland Clinic Cancer Institute
Ryan Mattison
Assistant Professor of Hematology & Oncology
University of Wisconsin School of Medicine and Public Health
Laura Michaelis, MD
Associate Professor of Medicine
Medical College of Wisconsin
Parameswaran Hari, MD, MS
Armand Quick Professor of Hematology
Director of Adult Blood and Marrow Transplant Program
Section Head of Hematologic Malignancies and BMT
Professor of Medicine
Medical College of Wisconsin
Paul Hosking, MD
Medical College of Wisconsin
Ehab Atallah, MD
Associate Professor of Medicine
Medical College of Wisconsin
All persons in control of content have NO relevant relationships to disclose with the exception of:
Parameswaran Hari, MD, MS, Celgene, Takeda
Ryan Mattison, MD, CTI Biopharma
Jaroslaw Maciejewski, MD, Celgene, Alexion
Laura Michaelis, MD, Incyte, Pfizer, Celgene
In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.
Available Credit
- 3.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.50 Hours of ParticipationHours of Participation credit.